Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1991016909) PHARMACEUTICAL COMPOSITION
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1991/016909 International Application No.: PCT/HU1991/000018
Publication Date: 14.11.1991 International Filing Date: 10.05.1991
Chapter 2 Demand Filed: 08.11.1991
IPC:
A61K 33/42 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33
Medicinal preparations containing inorganic active ingredients
42
Phosphorus; Compounds thereof
Applicants:
S+V ENGINEERING KFT, HUNGARY [HU/HU]; Bocskay út 21 H-1114 Budapest, HU (AllExceptUS)
SIKTER, András [HU/HU]; HU (UsOnly)
Inventors:
SIKTER, András; HU
Agent:
DANUBIA; Bajcsy Zsilinszky ut 16 H-1368 Budapest, HU
Priority Data:
2980/9010.05.1990HU
Title (EN) PHARMACEUTICAL COMPOSITION
(FR) COMPOSITION PHARMACEUTIQUE
Abstract:
(EN) A pharmaceutical composition is provided which comprises zinc, magnesium, phosphorus and potassium, wherein the weight ratio based on zinc, magnesium, phosphorus and potassium atoms is in the range of 1-15:25-300:50-600:100-1,200 optionally in association with a pharmaceutical carrier or excipient or additive. Use of said composition for regenerating living cells and method for regenerating living cells which comprises administering a therapeutic amount of said composition.
(FR) L'invention a pour objet une composition pharmaceutique qui comprend du zinc, du magnésium, du phosphore et du potassium, dans laquelle le rapport en poids basé sur les atomes de zinc, de magnésium, de phosphore et de potassium se situe dans la plage de 1-15:25-300:50-600:100-1200, éventuellement associée à un porteur pharmaceutique, un excipient ou un additif. Utilisation de ladite composition pour régénérer des cellules vivantes et procédé de régénération de cellules vivantes qui comprend l'administration d'une dose thérapeutique de ladite composition.
Designated States: AU, CA, FI, NO, SU, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0530220CA2082275AU1991077675